Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study

Leukemia. 2015 Jul;29(7):1602-4. doi: 10.1038/leu.2015.14. Epub 2015 Jan 30.

¹ German CLL Study Group (GCLLSG), Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University of Cologne, Cologne, Germany.
² Oncology Practice, Würzburg, Germany.
³ Department of Hematology, Centre Henri Becquerel, Rouen, France.
⁴ Department of Hematology, Hospital Virgen de la Salud, Toledo, Spain.
⁵ Department of Hematology and Oncology, Ospedale Niguarda Ca' Granda, Milan, Italy.
⁶ Department of Hematology, University Hospital of Wales, Cardiff, UK.
⁷ F. Hoffmann-La Roche Ltd, Basel, Switzerland.
⁸ F. Hoffmann-La Roche Ltd, Welwyn, UK.
⁹ 1] German CLL Study Group (GCLLSG), Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University of Cologne, Cologne, Germany [2] Cluster of Excellence 'Cellular Stress Responses in Aging Associated Diseases' (CECAD), University of Cologne, Cologne, Germany.

No abstract available

Publication types